| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 75.649 | 309.039 | 402.655 | 1.624.629 |
| Total Income - EUR | - | - | - | - | - | 0 | 75.700 | 309.156 | 402.770 | 1.624.984 |
| Total Expenses - EUR | - | - | - | - | - | 776 | 55.796 | 224.439 | 323.251 | 1.278.877 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -776 | 19.904 | 84.717 | 79.519 | 346.107 |
| Net Profit/Loss - EUR | - | - | - | - | - | -776 | 17.980 | 82.581 | 76.770 | 302.368 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 2 | 3 |
Check the financial reports for the company - Rosalvamed Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 53 | 1.699 | 857 | 7 | 5.746 |
| Current Assets | - | - | - | - | - | 1.487 | 54.935 | 136.134 | 206.021 | 501.970 |
| Inventories | - | - | - | - | - | 0 | 20.899 | 75.235 | 134.372 | 229.112 |
| Receivables | - | - | - | - | - | 0 | 15.838 | 43.689 | 48.547 | 92.146 |
| Cash | - | - | - | - | - | 1.487 | 18.198 | 17.211 | 23.102 | 180.712 |
| Shareholders Funds | - | - | - | - | - | -734 | 17.262 | 93.407 | 165.502 | 384.675 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.274 | 39.372 | 43.583 | 40.526 | 123.126 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Rosalvamed Plus S.r.l.